Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 11, 2012, Pages 1207-1212

  Horka, Petra ^a,b   Malickova, Karin ^a,b   Jarosova, Radka ^a,c   Janatkova, Ivana ^a,b   Zima, Tomas ^a,b   Kalousova, Marta ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Department of Gynecology and Obstetrics ^*  (Czech Republic)

Author keywords

Follicular fluid; In vitro fertilization; Matrix metalloproteinase; MMP 2; MMP 9; Pregnancy

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; EMBRYO TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY FOLLICLE FLUID; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; INFERTILITY, FEMALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PREGNANCY;

EID: 84878358420     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9853-4     Document Type: Article

References (26)

1. Baka S, Zourla K, Kouskouni E, Makrakis E, Demeridou S, Tzanakaki D, Hassiakos D, Creatsas G. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation. In Vivo. 2010;24(3):293-6.
2. Baka S, Zourla K, Malamitsi-Puchner A, Makrakis E, Kaparos G, Demeridou S, Moustakarias T, Tzanakaki D, Hassiakos D, Kouskouni E. Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle. In Vivo. 2009;23(1):89-92.
3. Bischof P, Meisser A, Campana A. Control of MMP-9 expression at the maternal-fetal interface. J Reprod Immunol. 2002;55(1-2):3-10.
4. Curry Jr TE, Song L, Wheeler SE. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol Reprod. 2001;65(3):855-65.
5. Curry Jr TE, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003;24(4):428-65.
6. D'Ascenzo S, Giusti I, Millimaggi D, Marci R, Tatone C, Colonna RC, Moscarini M, Pavan A, et al. Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment. Eur J Endocrinol. 2004;151(1):87-91.
7. Dubois B, Arnold B, Opdenakker G. Gelatinase B deficiency impairs reproduction. J Clin Invest. 2000;106(5):627-8.
8. Eng J. ROC analysis: web-based calculator for ROC curves. Baltimore: Johns Hopkins University, 2006. Available from: http://www.jrocfit.org.
9. Fu J, Wang XJ, Wang YW, Sun J, Gemzell-Danielsson K, Sun XX. The influence of early cleavage on embryo developmental potential and IVF/ICSI outcome. J Assist Reprod Genet. 2009;26(8):437-41.
10. Gomes VA, Vieira CS, Jacob-Ferreira AL, Belo VA, Soares GM, Fernandes JB, Ferriani RA, Tanus-Santos JE. Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome. Mol Cell Biochem. 2011;353(1-2):251-7.
11. Gottsch ML, Van Kirk EA, Murdoch WJ. Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes. Reproduction. 2002;124:347-52.
12. Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y, Takayama M. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer. 2003;97(1):79-89.
13. Jovanović M, Stefanoska I, Radojcić L, Vićovac L. Interleukin-8 (CXCL8) stimulants trophoblast cell migration and invasion by increasing levels of matrix metalloporteinase (MMP)2 and (MMP)9 and integrin alpha5 and beta1. Reproduction. 2010;139(4):789-98.
14. Koucký M, Germanová A, Kalousová M, Hill M, Cindrová-Davies T, Pařízek A, Svarcová J, Zima T. Low maternal serum matrix metalloproteinases (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response. J Perinat Med. 2010;38(6):589-96.
15. Lee DM, Lee TK, Song HB, Kim CH. The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilization pregnancy. BJOG. 2005;112(7):946-51.
16. Liu B, Cai LY, Lv HM, Xia L, Zhang YJ, Zhang HX, Guan YM. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1. Gynecol Endocrinol. 2008;24(5):285-8.
17. Naruse K, Lash GE, Innes BA, Otun HA, Searle RF, Robson SC, Bulmer JN. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum Reprod. 2009;24(3):553-61.
18. Ny T, Wahlberg P, Brändström IJ. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocrinol. 2002;187(1-2):29-38.
19. Ogiwara K, Takano N, Shinohara M, Murakami M, Takahashi T. Gelatinase A and membrane-type matrix metalloproteinases 1 and 2 are responsible for follicle rupture during ovulation in the medaka. Proc Natl Acad Sci U S A. 2005;102(24):8442-7.
20. O'Sullivan MJB, Stamoui A, Thomas ES, Richardson MC. Gonadotropin regulation of production of tissue inhibitor of metalliproteinases and by luteinized human granulated cells a potential mechanism for luteal rescue. Mol Hum Reprod. 1997;3:405-14.
21. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8(3):221-33.
22. Riley SC, Gibson AH, Leask R, Mauchline DJW, Pedersen HG, Watson ED. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries. Reproduction. 2001;121:553-60.
23. Russell L, Salamunsen LA, Findlay LR. Immunization against the N-terminal peptide of the inhibin alphaY3-subunit (Alpha N) disrupts tissue remodeling and the increase in matrix metalloproteinase-2 during ovulation. Endocrinology. 1995;136:3657-64.
24. Seval Y, Cakmak H, Kayisli UA, Arici A. Estrogen-mediated regulation of p38 mitogen-activated protein kinase in human endometrium. J Clin Endocrinol Metab. 2006;91(6):2349-57.
25. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Dev Biol. 2001;17:463-516.
26. Tsafriri A, Reich R. Molecular aspects of mammalian ovulation. Exp Clin Endocrinol Diabetes. 1999;107(1):1-11.